Loading...
Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Aim: To verify the superiority of pemafibrate over placebo and the non-inferiority of pemafibrate to the maximum dose of fenofibrate for determining the percent change in fasting serum triglyceride (TG) levels and to investigate safety by assessing the incidence of adverse events (AEs) and adverse d...
Na minha lista:
| Udgivet i: | J Atheroscler Thromb |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Japan Atherosclerosis Society
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6005227/ https://ncbi.nlm.nih.gov/pubmed/29628483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.44412 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|